Welcome to LookChem.com Sign In|Join Free

CAS

  • or
ascidiacyclamide is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

86701-12-4 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 86701-12-4 Structure
  • Basic information

    1. Product Name: ascidiacyclamide
    2. Synonyms: ascidiacyclamide;[1S,15S,(+)]-15,32-Seco-1-de(methyldithiomethyl)-8,22-dide(2-methylpropyl)-8,22-bis(1-methylethyl)-1,15-bis(1-methylpropyl)ulithiacyclamide
    3. CAS NO:86701-12-4
    4. Molecular Formula: C36H52N8O6S2
    5. Molecular Weight: 756.97808
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 86701-12-4.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 993.1°Cat760mmHg
    3. Flash Point: 554.4°C
    4. Appearance: /
    5. Density: 1.43g/cm3
    6. Vapor Pressure: 0mmHg at 25°C
    7. Refractive Index: 1.682
    8. Storage Temp.: N/A
    9. Solubility: N/A
    10. CAS DataBase Reference: ascidiacyclamide(CAS DataBase Reference)
    11. NIST Chemistry Reference: ascidiacyclamide(86701-12-4)
    12. EPA Substance Registry System: ascidiacyclamide(86701-12-4)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 86701-12-4(Hazardous Substances Data)

86701-12-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 86701-12-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,6,7,0 and 1 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 86701-12:
(7*8)+(6*6)+(5*7)+(4*0)+(3*1)+(2*1)+(1*2)=134
134 % 10 = 4
So 86701-12-4 is a valid CAS Registry Number.
InChI:InChI=1/C36H52N8O6S2/c1-11-17(7)25-33-43-27(19(9)49-33)31(47)39-24(16(5)6)36-38-22(14-52-36)30(46)42-26(18(8)12-2)34-44-28(20(10)50-34)32(48)40-23(15(3)4)35-37-21(13-51-35)29(45)41-25/h13-20,23-28H,11-12H2,1-10H3,(H,39,47)(H,40,48)(H,41,45)(H,42,46)/t17-,18-,19+,20+,23+,24+,25-,26-,27-,28-/m0/s1

86701-12-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name Ascidiacyclamide

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:86701-12-4 SDS

86701-12-4Downstream Products

86701-12-4Relevant articles and documents

NEW METHODS AND REAGENTS IN ORGANIC SYNTHESIS. 51. A SYNTHESIS OF ASCIDIACYCLAMIDE, A CYTOTOXIC CYCLIC PEPTIDE FROM ASCIDIAN - DETERMINATION OF ITS ABSOLUTE CONFIGURATION

Hamada, Yasumasa,Kato, Shinji,Shioiri, Takayuki

, p. 3223 - 3226 (1985)

A first synthesis of ascidiacyclamide, a cytotoxic cyclic peptide from ascidian, has been achieved through the cyclodimerization with diphenyl phosphorazidate (DPPA), wich has unambiguously determined the absolute configuration of ascidiacyclamide as 1.

IN VITRO PRODUCTION OF CYCLIC PEPTIDES

-

Sheet 26/29, (2015/11/28)

This invention relates to the in vitro production of cyclic peptides using cyanobacterial enzymes, such as patellamide biosynthesis enzymes. Linear peptide substrates are cyclized using an isolated cyanbacterial macrocyclase, such as PatG from Prochloron spp. Before cyclisation, residues in the linear peptide substrates may be heterocyclised using isolated cyanbacterial heterocyclases, such as PatD or TruD heterocyclase. Methods of the invention may be useful, for example, for the production of cyclic peptidyl molecules, including cyclotides, such as katalas, and cyanobactins, such as patellamides and telomestatins, for example for use in the development of therapeutics.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 86701-12-4